Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026)
Astrazeneca (AZN) posted quarterly FCF Payout Ratio of 3.54 for Q2 2026, up 19.88% year-over-year from 2.95 in Q2 2025, and up 41.08% quarter-over-quarter from 6.01 in Q1 2026.
Astrazeneca (AZN) FCF Payout Ratio (2009 - 2026) Analysis & Trends
Astrazeneca's FCF Payout Ratio history runs 17 years deep, the most recent figure standing at 3.54 for Q2 2026.
- In Q2 2026, FCF Payout Ratio rose 19.88% year-over-year to 3.54; the TTM figure through Jun 2026 stood at 1.62 (up 44.17% YoY), while the FY2025 annual figure was 0.31, down 5.6% from the prior year.
- FCF Payout Ratio for Q2 2026 stood at 3.54, up from 6.01 in the prior quarter.
- The five-year high for FCF Payout Ratio was 0.04 in Q2 2024, with the low at 13.57 in Q1 2022.
- The 5-year median for FCF Payout Ratio is 3.78 (2024), against an average of 5.14.
- The sharpest annual moves came in 2024 and 2025: FCF Payout Ratio soared 45.38% in 2024, then plunged 9830.31% in 2025.
- Astrazeneca's FCF Payout Ratio stood at 13.57 in 2022, then jumped by 99.4% to 0.08 in 2023, then sank by 3517.33% to 2.95 in 2024, then increased by 26.44% to 2.17 in 2025, then sank by 63.3% to 3.54 in 2026.
- Business Quant data shows AZN's FCF Payout Ratio at 3.54 in Q2 2026, 6.01 in Q1 2026, and 2.17 in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 0.44 |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 0.99 |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 0.48 |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 0.52 |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | -3.54 |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 0.39 |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 0.30 |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 8.12 |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -3.54 |
| Mar 31, 2026 | -6.01 |
| Dec 31, 2025 | -2.17 |
| Sep 30, 2025 | -2.91 |
| Jun 30, 2025 | -4.42 |
| Mar 31, 2025 | -7.80 |
| Dec 31, 2024 | -2.95 |
| Sep 30, 2024 | -3.78 |
| Jun 30, 2024 | -0.04 |
| Mar 31, 2024 | -7.27 |
| Jun 30, 2023 | -0.08 |
| Mar 31, 2023 | -12.34 |
| Mar 31, 2022 | -13.57 |
| Dec 31, 2021 | -4.15 |
| Sep 30, 2021 | -5.33 |
| Mar 31, 2021 | -11.22 |
| Mar 31, 2020 | -12.89 |
| Sep 30, 2019 | -5.49 |
| Mar 31, 2019 | 11.42 |
| Sep 30, 2018 | -4.82 |